Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis? 2014

Emily Choi Decroos, and Lisa D Hobson-Webb, and Vern C Juel, and Janice M Massey, and Donald B Sanders
Neuromuscular Section, Division of Neurology, Department of Medicine, Duke University Medical Center, DUMC 3403, Durham, North Carolina, 27710, USA.

BACKGROUND Acetylcholine receptor (AChR) and striated muscle antibodies (StrAbs) are found frequently in myasthenia gravis (MG) patients with thymoma. In this study we aimed to determine the positive predictive value (PPV) and negative predictive value (NPV) of these antibodies for thymoma in patients with MG. METHODS Antibody findings, thymic histology, and onset age were reviewed for 1141 patients with MG. PPV and NPV of these antibodies for thymoma were determined. RESULTS The PPV of AChR binding antibodies plus StrAbs was highest (50.0%) with onset before the age of 40 years. The PPV of all antibodies was low (<9%) after age 40. Higher StrAb levels did not increase the PPV. The NPV of AChR binding antibodies was high (99.7%) for all ages. CONCLUSIONS Patients without AChR binding antibody are not likely to have a thymoma. StrAbs and AChR binding antibodies are not diagnostic for thymoma, but in early-onset MG their presence should raise the clinical suspicion for thymoma.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Emily Choi Decroos, and Lisa D Hobson-Webb, and Vern C Juel, and Janice M Massey, and Donald B Sanders
March 2011, Journal of the neurological sciences,
Emily Choi Decroos, and Lisa D Hobson-Webb, and Vern C Juel, and Janice M Massey, and Donald B Sanders
February 1980, Neurology,
Emily Choi Decroos, and Lisa D Hobson-Webb, and Vern C Juel, and Janice M Massey, and Donald B Sanders
September 1991, Clinica chimica acta; international journal of clinical chemistry,
Emily Choi Decroos, and Lisa D Hobson-Webb, and Vern C Juel, and Janice M Massey, and Donald B Sanders
January 1988, Monographs in allergy,
Emily Choi Decroos, and Lisa D Hobson-Webb, and Vern C Juel, and Janice M Massey, and Donald B Sanders
June 1976, Lancet (London, England),
Emily Choi Decroos, and Lisa D Hobson-Webb, and Vern C Juel, and Janice M Massey, and Donald B Sanders
October 1975, The New England journal of medicine,
Emily Choi Decroos, and Lisa D Hobson-Webb, and Vern C Juel, and Janice M Massey, and Donald B Sanders
April 1983, Harefuah,
Emily Choi Decroos, and Lisa D Hobson-Webb, and Vern C Juel, and Janice M Massey, and Donald B Sanders
January 1981, Muscle & nerve,
Emily Choi Decroos, and Lisa D Hobson-Webb, and Vern C Juel, and Janice M Massey, and Donald B Sanders
August 2008, Neuromuscular disorders : NMD,
Emily Choi Decroos, and Lisa D Hobson-Webb, and Vern C Juel, and Janice M Massey, and Donald B Sanders
April 1984, Klinische Wochenschrift,
Copied contents to your clipboard!